Every major technological breakthrough in history has reshaped the economy. And almost every one has also produced a financial bubble. From railroads in the 1800s to the Internet in the 1990s, investors have repeatedly overestimated how fast innovation would deliver profits—and who would ultimately benefit. In 2025, with U.S. equity valuations near historic highs and artificial intelligence dominating market narratives,[…]
Read moreFor more than a century, scholars, traders, and investors have sought to decode the elusive recipe behind stock market winners. Why do some companies grow exponentially, turning early shareholders into multi-millionaires, while others with seemingly comparable resources stagnate or even collapse? Traditional finance offers an arsenal of analytical tools—price-to-earnings ratios, price-to-book multiples, debt-to-equity, and discounted cash flow models. Yet these[…]
Read moreOscar Health, Inc. (NYSE: OSCR), a technology-driven health insurance company, has long divided Wall Street analysts. While some see a speculative bet with unsustainable losses, others — like myself — view it as a misunderstood growth story with the potential to deliver exponential returns. If Oscar’s operational fears dissipate, and its valuation multiples expand to align with sector peers, I[…]
Read more